Krka UK’s animal health portfolio includes effective treatments for both companion and food-producing animals. Key brands include Milprazon CHEWABLE® for comprehensive worm control in dogs and cats, and Tolracol® for managing coccidiosis in cattle and sheep. Recent innovations in the companion animal range feature Robexera® for targeted pain relief, Cladaxxa® for infection management, Otomicol® for the treatment of otitis externa and our new antiemetic Arocenia (maropitant).  

We partner closely with our customers to provide licensed medicines that are proven in clinical practice. With European-based manufacturing, Krka ensures high-quality production standards, while its vertically integrated R&D and supply chain enable rapid response to market needs and optimised product availability.